A. Suleman

Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity.

X. Jacq, J. Nissink, I. Hickson, 2013, Journal of medicinal chemistry.

Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity.

S. Boyer, C. Donald, A. Turnbull, 2002, Journal of medicinal chemistry.

Palladium- and ruthenium-catalyzed cycloisomerization of enynamides and enynhydrazides: a rapid approach to diverse azacyclic frameworks.

E. Anderson, A. Suleman, C. D. Campbell, 2013, Angewandte Chemie.

Optimized scale up of 3-pyrimidinylpyrazolo[1,5- a ]pyridine via Suzuki coupling; a general method of accessing a range of 3-(hetero)arylpyrazolo[1,5- a ]pyridines

G. Lamont, Paul A. Bethel, P. Kemmitt, 2012 .

A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.

James S. Scott, B. Barlaam, R. Ducray, 2008, Bioorganic & medicinal chemistry letters.

Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.

James S. Scott, B. Barlaam, R. Bradbury, 2007, Bioorganic & Medicinal Chemistry Letters.